| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/18/2002 | WO2002011740A3 'slow release' pharmaceutical compositions comprising lithium carbonate |
| 04/18/2002 | WO2002008217A3 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS |
| 04/18/2002 | WO2002008177A8 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 04/18/2002 | WO2001091732A3 Medicament for combating respiratory depression |
| 04/18/2002 | WO2001085188A3 Use of echinacea as a hematinic agent |
| 04/18/2002 | WO2001082952A3 USE OF α-MSH AND EPO FOR PREVENTING OR TREATING ISCHEMIC CONDITIONS |
| 04/18/2002 | WO2001072777A3 Human transcription factors |
| 04/18/2002 | WO2001072289A3 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof |
| 04/18/2002 | WO2001070209A3 Mono- and disaccharides for the treatment of nitric oxide related disorders |
| 04/18/2002 | WO2001068570A3 Il-8 receptor antagonists |
| 04/18/2002 | WO2001068569A3 Il-8 receptor antagonists |
| 04/18/2002 | WO2001064911A3 18232, a dual specificity phosphatase |
| 04/18/2002 | WO2001058893A3 Indol-3-yl derivatives and their use as integrin inhibitors |
| 04/18/2002 | WO2001025437A3 Growth factor polypeptides and nucleic acids encoding same |
| 04/18/2002 | US20020045623 Stable; potent; penetrates cell membranes; effectively hinders cellular apoptosis; Antiinflammatory agents, Ischemic agents, cancer, autoimmune diseases and nervous system disorders. |
| 04/18/2002 | US20020045616 Lactam inhibitors of FXa and method |
| 04/18/2002 | US20020045593 Use of the interferon receptor 2c polypeptide chain to enhance the anti-growth effects of type I interferons |
| 04/18/2002 | US20020045589 Hirulogs are a group of synthetic thrombin-specific inhibitors which conserve the major active sites of hirudin; treatment of vascular restenosis |
| 04/18/2002 | US20020045586 Mono-and disaccharides for the treatment of nitric oxide related disorders |
| 04/18/2002 | US20020045581 Method for reducing or preventing the establishment, growth or metastasis of cancer by administering PAR-1 and optionally PAR-2 antagonists |
| 04/18/2002 | US20020045264 Expression vectors for use in gene therapy |
| 04/18/2002 | US20020045240 Solid phase extraction of the sources containing the components to be separated on anion exchanger materials in loose bulk, on membranes and/or on compact disks,removal of effluent; elution of adsorbed material, fractionation |
| 04/18/2002 | CA2425835A1 Methods and compositions for nucleic acid delivery |
| 04/18/2002 | CA2425678A1 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | CA2425674A1 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | CA2425650A1 Methods for the treatment of a traumatic central nervous system injury |
| 04/18/2002 | CA2425121A1 Ether compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | CA2425001A1 Novel serine protease genes related to dppiv |
| 04/18/2002 | CA2424983A1 Nucleic acid molecules and polypeptides for immune modulation |
| 04/18/2002 | CA2424292A1 Tricyclic compounds and uses thereof |
| 04/18/2002 | CA2394084A1 Inhibitors of protein kinases |
| 04/17/2002 | EP1197550A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
| 04/17/2002 | EP1197218A1 Algae protein polysaccharide extraction and use thereof |
| 04/17/2002 | EP1197147A1 Method of inactivating viral particles in a blood product |
| 04/17/2002 | EP1196782A1 Catalytic anti-factor viii allo-antibodies |
| 04/17/2002 | EP1196610A2 Ecarin polypeptides, polynucleotides encoding ecarin, and methods for use thereof |
| 04/17/2002 | EP1196577A2 Cell cycle and proliferation proteins |
| 04/17/2002 | EP1196574A2 Human proteins involved in detoxification |
| 04/17/2002 | EP1196569A2 Electron transfer proteins |
| 04/17/2002 | EP1196568A1 Human lim domain proteins |
| 04/17/2002 | EP1196567A2 Human immune response molecules |
| 04/17/2002 | EP1196443A2 Erythropoietin conjugates with polyethylenglycol |
| 04/17/2002 | EP1196441A1 Keratinocyte growth factor-2 |
| 04/17/2002 | EP1196440A2 Therapeutic peptides derived from subsequences of bpi |
| 04/17/2002 | EP1196433A2 CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN ALPHA v BETA 6 |
| 04/17/2002 | EP1196432A2 FVIIa ANTAGONISTS |
| 04/17/2002 | EP1196431A1 A substantially crystalline form of melagatran |
| 04/17/2002 | EP1196412A1 Nitrogen containing heterobicycles as factor xa inhibitors |
| 04/17/2002 | EP1196411A1 Bradykinin b1 receptor antagonists |
| 04/17/2002 | EP1196404A1 Piperazine derivatives as modulators of chemokine receptor activity |
| 04/17/2002 | EP1196392A1 6-carboxyphenyldihydropyridazinone derivatives and use thereof |
| 04/17/2002 | EP1196390A2 Pyrazole compositions useful as inhibitors of erk |
| 04/17/2002 | EP1196379A2 INHIBITORS OF FACTOR Xa |
| 04/17/2002 | EP1196190A1 Use of long-chain n-alkyl derivatives of deoxynojirimycin and a glucocerebrosidase enzyme for the manufacture of a medicament for the treatment of glycolipid storage diseases |
| 04/17/2002 | EP1196188A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 04/17/2002 | EP1196186A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 04/17/2002 | EP1196173A2 Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and use thereof |
| 04/17/2002 | EP1196152A1 Use of cortisol antagonists in the treatment for heart failure |
| 04/17/2002 | EP1196047A1 Prophylactic dietary supplement based on milk |
| 04/17/2002 | EP1196030A1 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 04/17/2002 | EP1196029A2 A device and method for performing a biological modification of a fluid |
| 04/17/2002 | EP1152755B1 Essential fatty acids in the prevention of cardiovascular events |
| 04/17/2002 | EP1007561B1 Novel conjugates of opioids and endogenous carriers |
| 04/17/2002 | EP0998475B1 Novel compounds |
| 04/17/2002 | EP0996620B1 Novel compounds |
| 04/17/2002 | EP0876152B1 Novel administration of thrombopoietin |
| 04/17/2002 | EP0851762B1 Pharmaceutical combination preparations containing erythropoietin and iron preparations |
| 04/17/2002 | EP0807632B1 Pyrroloazepine derivatives |
| 04/17/2002 | CN1345376A Protease, gene therefor and use thereof |
| 04/17/2002 | CN1345335A Melanocortin receptor ligands |
| 04/17/2002 | CN1345334A Antibodies specific to KDR and uses thereof |
| 04/17/2002 | CN1345329A Tumor mecrosis factor receptors 6 alpha and beta |
| 04/17/2002 | CN1345312A Dibenzoazulene derivatives for treating thrombosis, osteoporosis arteriosclerosis |
| 04/17/2002 | CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors |
| 04/17/2002 | CN1345247A Expression vectors and cell lines expressing vascular endothelial growth factor D, and method of treating melanomas |
| 04/16/2002 | US6372919 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent |
| 04/16/2002 | US6372796 Increasing hematopietic stem cells |
| 04/16/2002 | US6372768 2-aminopyridines containing fused ring substituents |
| 04/16/2002 | US6372759 Antithrombotic agents |
| 04/16/2002 | US6372758 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 04/16/2002 | US6372751 Drugs with benzene and pyrimidine rings |
| 04/16/2002 | US6372716 Freeze dried mixture with glycine, polysorbate, sucrose, and histidine; storage stability |
| 04/16/2002 | US6372473 Tissue plasminogen activator-like protease |
| 04/16/2002 | US6372423 For use in dioagnosis such as tests for diagnosing heparin-associated thrombocytopenia (hat), therapy |
| 04/16/2002 | US6372267 Cocoa solids prepared by heating, pressing, recovering partially defatted cocoa solids which contain cocoa polyphenols including cocoa procyanidins |
| 04/16/2002 | US6372213 Method of treating sickle cell disease or thalassemia |
| 04/16/2002 | US6372196 Hemostatically active aerosol composition of polyanhydroglucoronic acids and its salts |
| 04/16/2002 | US6371975 Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers |
| 04/11/2002 | WO2002029084A2 Industrial-scale serum-free production of recombinant factor vii in mammalian cells |
| 04/11/2002 | WO2002029083A2 Industrial-scale serum-free production of recombinant proteins in mammalian cells |
| 04/11/2002 | WO2002029073A2 Gene delivery vectors for stem cells |
| 04/11/2002 | WO2002029061A2 G-protein coupled receptors |
| 04/11/2002 | WO2002029060A2 Hematopoietin receptors hpr1 and hpr2 |
| 04/11/2002 | WO2002029058A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | WO2002029055A2 Carbohydrate-associated proteins |
| 04/11/2002 | WO2002029045A2 Method for the production of vitamin k-dependent proteins |
| 04/11/2002 | WO2002029038A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | WO2002029036A2 Lipid metabolism enzymes |
| 04/11/2002 | WO2002029025A2 Factor vii glycoforms |
| 04/11/2002 | WO2002028902A2 Nectin polypeptides, polynucleotides, methods of making and use thereof |